Maintaining a cancer service in the midst of the COVID-19 pandemic: A single centre experience
Shared learning database Organisation: Bristol Haematology and Oncology Centre Published date: August
Search results
359 results
-
-
Transforming the care of children and young people in London with asthma: Development of the London Asthma Standards
Shared learning database Organisation: Healthy London Partnership, part of North East London CSU Published date:
-
Sun Safe Schools Accreditation – National intervention programme
Shared learning database Organisation: Skcin – National skin cancer charity Published date: April 2021
-
East of England Stroke Telemedicine Stakeholder Partnership
Shared learning database Organisation: East of England Stroke Telemedicine Partnership Published date:
-
Croydon Integrated Community Network Medicines Optimisation Service
Shared learning database Organisation: Croydon Clinical Commissioning Group Published date: February
-
Dudley Falls Prevention Service
Shared learning database Organisation: Dudley Falls Prevention Service Published date: July 2019
-
Manchester Royal Infirmary Virtual Biologics Clinic
Shared learning database Organisation: British Society for Rheumatology and Manchester Royal Infirmary Published date:
-
Overcoming the challenges of implementing the new NICE guidance for suspected cancer: recognition and referral
Shared learning database Organisation: Blackburn with Darwen CCG and East Lancashire CCG Published date:
-
Integrated Respiratory Action Network Group for patients with Chronic Obstructive Pulmonary Disease (COPD)
Shared learning database Organisation: The Royal Wolverhampton NHS Trust Published date: July 2017
-
Empowering patients to be their own personal trainers to improve function and strength - Implementing NICE NG100
Shared learning database Organisation: Royal Derby Hospital and British Society for Rheumatology Published date:
-
COVID-19 ready rehabilitation for heart failure: REACH-HF can deliver
Shared learning database Organisation: The REACH-HF Collaboration Published date: December 2020
-
MoreLife MUMS2B (expecting parents) and 4MUMS (new parents)
Shared learning database Organisation: MoreLife Published date: April 2021
-
Minimising Risks of COVID-19 across Maternity Services
Shared learning database Organisation: Betsi Cadwaladr University Health Board (BCUHB) Published date:
-
Managing COVID symptoms (including at the end of life) in a prison setting. Implementing NG163
Shared learning database Organisation: Hanham Secure Health Published date: April 2021
-
The Integrated Pain and Spinal Service (IPASS): A unique, integrated and collaborative approach to persistent pain management
Shared learning database Organisation: Berkshire West NHS Foundation Trust Published date: April 2018
-
Young Adult Diabetes: Engaging to improve; outcomes of the young adult clinic restructure
Shared learning database Organisation: Royal Liverpool & Broadgreen University Hospitals NHS Trust Published date:
-
Best evidence for a better back (BE FABB) - A triage, assessment and education service for patients with low back pain with or without sciatica
Shared learning database Organisation: Hillingdon Hospitals NHS Foundation Trust Published date: August
-
Chemotherapy-free treatment option to be offered to patients with England's most common leukaemia
Acalabrutinib, taken as a twice daily tablet, is recommended as an option for adults with untreated chronic lymphocytic leukaemia.
-
Unpaid carers should be offered advice and support, says NICE
NICE has today published a new quality standard aimed at improving the wellbeing of adults who provide unpaid care for people over 16 years old.
-
Triple therapy recommended by NICE for patients with multiple myeloma
The therapy has been recommended after a confidential discount was agreed between NHS England and the drug manufacturer Amgen.
-
NICE publishes single guideline for managing COVID-19
One year on from the first national lockdown, NICE has today (23 March) published a single guideline for the management of COVID-19 in children and adults.
-
Ovarian cancer patients to have NICE-approved drug combination option on Cancer Drugs Fund
A potentially life-extending drug combination for some people with advanced, high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer will now be available on the Cancer Drugs Fund (CDF), following its approval by NICE in draft guidance published today.
-
Starting with the end in mind - the Innovative Licensing and Access Pathway
Launched in January, the new Innovative Licensing and Access Pathway (ILAP) will smooth the process by which innovative new medicines are developed, speeding their progression from clinical trial through to the NHS. It is an exciting development that signals greater collaboration between the agencies involved and, we hope, should bring significant benefits to patients.
-
NICE recommends range of effective treatments for people with chronic primary pain and calls on healthcare professionals to recognise and treat a person's pain as valid and unique to them
People with chronic primary pain should be offered a range of treatments to help them manage their condition, NICE has said in its guideline on the assessment and management of chronic pain published today (7 April).
-
NICE welcomes appointment of six new Board members
NICE is delighted with today’s (15 March) announcement from the Department of Health & Social Care appointing six new non-executive directors to its Board following their approval by the Secretary of State.
-
NICE approves life-changing gene therapy for treating spinal muscular atrophy
A new and potentially curative one-off gene therapy for babies with the rare genetic disorder spinal muscular atrophy (SMA) is set to become the most expensive treatment ever approved by NICE.
-
Children and young people need accurate, accessible information about their healthcare
New draft guidance from NICE published today recommends ensuring children and young people are fully informed about their health so that they are empowered to take an active role in their healthcare.
-
Register now for the HTAi 2021 Virtual Annual Meeting
The Health Technology Assessment International (HTAi) 2021 Annual Meeting will be held virtually from 19-23 June 2021, and registration is now open.
-
Thousands of breast cancer patients to have routine access to NICE-approved drug combination
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available for routine use after draft guidance from NICE today (26 February) recommended ribociclib (also called Kisqali and made by Novartis) is taken out of the Cancer Drugs Fund (CDF).
-
Hundreds of people set to benefit as NICE recommends selective internal radiation therapy for treating advanced liver cancer
Hundreds of people with advanced liver cancer (also called hepatocellular carcinoma or HCC) are set to benefit after NICE today (26 February 2021) published final draft guidance recommending a cancer treatment called selective internal radiation therapy (SIRT) as an option for treating the condition
-
NICE draft guidance recommends sapropterin for children with rare inherited metabolic condition phenylketonuria
NICE has today (25 February 2021) issued draft guidance for public consultation which recommends sapropterin (also called Kuvan and made by BioMarin) for treating phenylketonuria (PKU) in children aged up to 18.
-
NHS patients to benefit from first full access deal in Europe for new CAR-T therapy recommended by NICE
NICE has agreed a managed access agreement, via the Cancer Drugs Fund with manufacturer Kite, so more data can be collected while patients can access the treatment.
-
A new instrument for consideration of a broader range of benefits for people, their families and carers
For the last three years, NICE has been part of a research project investigating how quality of life measures used to evaluate healthcare treatments such as drugs can be extended into areas of social care and public health
-
Skin cancer drug recommended for routine NHS use
An appeal period has now opened until 26 February 2021.
-
5-year strategy virtual event launch
Join us and share your questions as we launch our ambitious new 5-year strategy.
-
NICE recommends treatment options for severe pregnancy sickness in new draft guidance
Nausea and vomiting, often referred to as morning sickness, is common in pregnancy. Close to 80% of pregnant women experience these symptoms, with most conditions improving or stopping completely by around 16 to 20 weeks.
-
NICE's processes of technology evaluation - presenting a case for change
NICE has today (4 February 2021) launched a public consultation on proposals for changes to the processes it uses to develop its guidance on medicines, medical devices, diagnostics and digital health technologies.
-
Thousands of lung cancer patients to benefit from life-extending treatment
A potentially life-extending treatment for some people with non-squamous, non-small-cell lung cancer (NSCLC) will now be available on the NHS following its approval by NICE in draft guidance published today.
-
Speaking with one language: How using a common data model might speed up decision making
NICE is taking part in the European Health Data and Evidence Network (EHDEN) project, which is exploring the use of common data models for healthcare research. This could support faster patient access to innovative medicines in areas of unmet need.
-
NICE is gearing up for the evaluation of further digital health technologies as pilot project produces first result
Following the successful evaluation of Zio XT, developers of digital health technologies are encouraged to engage with NICE through one of several different routes
-
Treatment for men with enlarged prostate is recommended by NICE for NHS adoption
Final guidance from NICE recommends the PLASMA system
-
NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st
Companies can now submit medicines for the new Innovative Licensing and Access Pathway (ILAP) following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.
-
Shared decision making is an integral part of healthcare, says NICE
Shared decision making between patients and clinicians should be embedded throughout healthcare services, says NICE, in draft guidance published today.
-
NICE, RCGP and SIGN publish guideline on managing the long-term effects of COVID-19
NICE, the Royal College of General Practitioners (RCGP) and the Scottish Intercollegiate Guidelines Network (SIGN) have today (18 December 2020) published a guideline on the management of the long-term effects of COVID-19 (also known as Long COVID).
-
NICE, PHE and SACN publish rapid COVID-19 guidance on vitamin D
NICE, PHE and SACN have today published rapid guidance on vitamin D for COVID-19.
-
New LSE master's degree in Evaluation of Health Care Interventions and Outcomes
NICE is collaborating with the London School of Economics and Political Science (LSE) to develop an executive master’s degree in health care decision-making.
-
NICE and NIHR: working together to produce research with impact
Alice and Zoe discuss how the National Institute of Health Research (NIHR) and NICE work in partnership and identify key research priorities from NICE guidance.
-
Shared Learning Awards 2020: Winner announced
Virtual ceremony sees a project from Avon and Wiltshire Mental Health Partnership Trust voted winning submission
-
Innovative technology to detect abnormal heart rhythms recommended by NICE for NHS use while further data is collected
Zio ZT is the first assessment, via the NICE digital health technologies guidance development pilot project, to be recommended for NHS use with the caveat that further data must be collected.
-
How NICE is improving patient safety
Annual patient safety update covers the period from September 2019 to September 2020